Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

These 3 AI Stocks Just Crushed Earnings: Still Time To Buy?

STX, SIMO, and NXPI each surged after strong Q1 2026 earnings, but valuations and overbought technicals raise questions about remaining upside for each stock.

After 15% L3Harris Price Drop, Is It Time to Buy or Time to Fly?

After 15% L3Harris Price Drop, Is It Time to Buy or Time to Fly?

L3Harris is positioned to rebound and hit fresh highs but a lower low may come before it begins. Growth, margin, and market sentiment drive the action.

MarketBeat Week in Review – 04/27 - 05/01

MarketBeat Week in Review – 04/27 - 05/01

Sell in May and go away may not be the right strategy after stocks closed out a strong April and strong earnings point to more gains

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent

Eli Lilly's 2026 is off to a great start, with massive earnings and revenue beats and exciting updates about its latest GLP-1, Foundayo.

SanDisk Earnings Crush Estimates With 251% Revenue Surge

SNDK's Q3 revenue of $5.95 billion surged 251% YOY, with non-GAAP EPS crushing the $14.36 consensus by 63%, while Q4 sales and EPS guidance topped estimates by a wide margin.

MaxLinear’s Explosive 200% Rally Looks Impressive—But Can It Last?

MaxLinear surged 80% after Q1 2026 earnings on strong data center growth, but negative net margins and a forward P/E of 60 raise valuation concerns.

5 Reasons Rambus Stock Price Collapse Is One Hot Entry Point

Rambus is amid a shift from IP sales and licensing to product sales and it is paying off as AI demand supports growth and wider margins.

inkl

Read news from The Economist, FT, and more,
with one subscription

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge

Viking Therapeutics stock faces near-term pressure, but its GLP-1 pipeline and clinical timeline could deliver significant long-term upside

Bed Bath & Back to Life? An Aggressive Turnaround Takes Shape

Bed Bath & Back to Life? An Aggressive Turnaround Takes Shape

With its first revenue increase in nineteen quarters, Bed Bath & Beyond is aggressively executing a strategic pivot toward a unified home services model.

Apple’s Earnings Make $300 Look Like a Matter of When, Not If

Apple’s Earnings Make $300 Look Like a Matter of When, Not If

Apple’s earnings reinforced its bullish outlook, and a move back towards $300 is starting to look increasingly likely in the coming weeks.

Sherwin-Williams: The Boring Beauty Play on Housing Recovery

Sherwin-Williams: The Boring Beauty Play on Housing Recovery

Sherwin-Williams stock dips after earnings, but its long-term outlook as a housing recovery play and dividend compounder remains intact

T-Mobile's Broadband Blitz Puts Cable on Notice

T-Mobile's Broadband Blitz Puts Cable on Notice

T-Mobile is leveraging its wireless dominance to fund a strategic, capital-efficient expansion into the broadband market, directly challenging cable incumbents.

Bloom Energy May Be Solving AI’s Biggest Power Problem

Bloom Energy May Be Solving AI’s Biggest Power Problem

Bloom Energy is the power behind the data center build out, ramping production of its fuel cells and accelerating deployments.

5 Stocks to Buy in May Before the Next AI Surge Hits

5 Stocks to Buy in May Before the Next AI Surge Hits

The S&P 500 broke to new highs in April and signals a robust uptrend ahead, with the target now well above 7,500 and many tech stocks following suit.

Get all your
news in one place.

100's of premium titles.
One news app.

Microsoft Earnings Look Strong, But Investors Focus on Risks

Microsoft stock falls after earnings despite strong Azure growth and AI momentum as investors weigh capex spending and OpenAI risks

Is This Pre-IPO AI Robotics Company the Next Big Defense Play?

XTEND CEO Aviv Shapira explains the AI operating system behind autonomous drones, its Lockheed Martin partnership, and a planned $1.5B NASDAQ debut under XTND.

MongoDB Could Be Setting Up for a Sharp Earnings Rebound

MongoDB's unique database architecture enables easy use, easy scaling, and cost effective deployment of AI for enterprises across verticals.

Hilton’s Q1 Report Put One Big Question Front and Center for 2026

Hilton stock holds steady after Q1 earnings beat as broader travel demand and strong pipeline growth support its long-term outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Why CrowdStrike's Consolidation Bet Is the Only One That Matters

CrowdStrike’s platform strategy is gaining traction, driving strong ARR growth and positioning CRWD stock for long-term gains

Mondelez Rips Higher on a Q1 Beat as Cocoa Pressure Finally Starts to Crack

Mondelez stock rises on strong earnings, as easing cocoa costs and emerging-market growth point to potential upside for MDLZ investors.

Chipotle Stock Just Hit Bottom—Is a Breakout Next?

Chipotle Mexican Grill is on track for an accelerating rebound as improving store counts and comp sales combine to form a powerful tailwind.

Amazon’s Earnings Just Sent the Stock to New Highs—What’s Next?

Amazon’s blowout earnings confirm its AI-driven growth story, but after a sharp rally to new highs, the challenge now is sustaining that momentum.

Meta Posted Its Best Sales Growth Since 2021—So Why Did Shares Fall?

Meta posted robust beats during Q1 2026, but this wasn't enough to overcome increased spending forecasts and a lack of clarity around AI products.

Alphabet’s Earnings Didn’t Just Beat—They Changed the Story

Alphabet's Q1 2026 results topped estimates with $109.9 billion in revenue, up 22%, while Google Cloud surged 63% to $20 billion with a $460 billion backlog.

TFI Earnings Beat: Is This Stock the Freight Recovery King?

TFI International is demonstrating strong margin control and a cyclical recovery as its Less-Than-Truckload shipment volumes show significant expansion.

1 … 63 64 65 66

People

Jeffrey Neal Johnson

Jennifer Ryan Woods

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Emerging Markets

Places

387,259 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play